Specific immunotherapy: one size does not fit all.
Genain
C P
CP
Zamvil
S S
SS
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008024:Ligands; D009103:Multiple Sclerosis / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D004676:Myelin Basic Protein / Q000276:immunology / Q000378:metabolism; D010446:Peptide Fragments / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use*; D018417:Th1 Cells / Q000187:drug effects; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology
D008024:Ligands; D004676:Myelin Basic Protein; D010446:Peptide Fragments; C104448:myelin basic protein 83-99